Octreotide acetate successfully treated a bowel obstruction caused by peritoneally disseminated gastric cancer, thereby enabling the subsequent use of oral S-1 chemotherapy

International Journal of Clinical Oncology

Volumn 14, Issue 4, 2009, Pages 372-375

  Kumagai, Koshi ^a   Saikawa, Yoshiro ^a   Fukuda, Kazumasa ^a   Ito, Ryo ^a   Igarashi, Takahiro ^a   Tsuwano, Shinichi ^a   Nakamura, Rieko ^a   Takahashi, Tsunehiro ^a   Takeuchi, Hiroya ^a   Kitagawa, Yuko ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Chemoradiotherapy; Gastric cancer; Malignant bowel obstruction; Octreotide acetate; S 1

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; CISPLATIN; OCTREOTIDE;

AGED; ANAMNESIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CASE REPORT; CLINICAL FEATURE; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; FEMALE; GASTROINTESTINAL ENDOSCOPY; HUMAN; HUMAN TISSUE; INTESTINE OBSTRUCTION; LOW DRUG DOSE; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; SIGNET RING CARCINOMA; STOMACH BIOPSY; STOMACH CANCER; TREATMENT RESPONSE;

ADENOCARCINOMA; ADMINISTRATION, ORAL; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SIGNET RING CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DRUG COMBINATIONS; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; INTESTINAL OBSTRUCTION; NEOPLASM STAGING; OCTREOTIDE; OXONIC ACID; PERITONEAL NEOPLASMS; RADIOTHERAPY, ADJUVANT; STOMACH NEOPLASMS; TEGAFUR; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 69249198072     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-008-0886-8     Document Type: Article

References (23)

1. Japanese Gastric Cancer Association (1998) Japanese classification of gastric carcinoma - 2nd English edition
2. S. Mercadante A. Casuccio S. Mangione 2007 Medical treatment for inoperable malignant bowel obstruction: a qualitative systematic review J Pain Symptom Manage 33 217 223
3. C. Massacesi G. Galeazzi 2006 Sustained release octreotide may have a role in the treatment of malignant bowel obstruction Palliat Med 20 715 716
4. U.A. Matulonis M.V. Seiden M. Roche 2005 Long-acting octreotide for the treatment and symptomatic relief of bowel obstruction in advanced ovarian cancer J Pain Symptom Manage 30 563 569
5. G. Mangili G. Aletti L. Frigerio 2005 Palliative care for intestinal obstruction in recurrent ovarian cancer: a multivariate analysis Int J Gynecol Cancer 15 830 835
6. C. Ripamonti S. Mercadante L. Groff 2000 Role of octreotide, scopolamine butylbromide, and hydration in symptom control of patients with inoperable bowel obstruction and nasogastric tubes: a prospective randomized trial J Pain Symptom Manage 19 23 34
7. S. Mercadante C. Ripamonti A. Casuccio 2000 Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction Support Care Cancer 8 188 191
8. G. Mangili M. Franchi A. Mariani 1996 Octreotide in the management of bowel obstruction in terminal ovarian cancer Gynecol Oncol 61 345 348
9. S. Mercadante P. Ferrera P. Villari 2004 Aggressive pharmacological treatment for reversing malignant bowel obstruction J Pain Symptom Manage 28 412 416
10. A. Dean 2001 The palliative effects of octreotide in cancer patients Chemotherapy 47 Suppl2 54 61
11. D. Khoo E. Hall R. Motson 1994 Palliation of malignant intestinal obstruction using octreotide Eur J Cancer 30A 28 30
12. H. Watanabe Y. Inoue K. Uchida 2007 Octreotide improved the quality of life in a child with malignant bowel obstruction caused by peritoneal dissemination of colon cancer J Pediatr Surg 42 259 260
13. Y. Shima K. Yamaguchi Y. Miyata 2004 A clinical study using octreotide in relieving gastrointestinal symptoms due to bowel obstruction in a terminally ill cancer patient Gan To Kagaku Ryoho 31 1377 1382
14. T.F. Marie 1994 The physiology of somatostatin and its synthetic analogue, octreotide Eur J Palliative Care 1 20 22
15. S. Mercadante J. Kargar G. Nicolosi 1997 Octreotide may prevent definitive intestinal obstruction J Pain Symptom Manage 13 352 355
16. S. Sakuramoto M. Sasako T. Yamaguchi 2007 Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine N Engl J Med 357 1810 1820
17. Y. Saikawa A. Kubo M. Kitajima 2006 A recent trial of chemo-radiation with S-1 against gastric cancer Gan To Kagaku Ryoho 33 Suppl1 99 105
18. Y. Saikawa T. Kubota M. Kitajima 2005 Is chemoradiation effective or harmful for stage IV gastric cancer patients? Oncol Rep 13 865 870
19. Y. Saikawa T. Kubota M. Kitajima 2003 Preoperative combination chemotherapy with S-1 and low-dose cisplatin against highly advanced gastric carcinoma Oncol Rep 10 381 386
20. Y. Saikawa T. Kubota M. Kitajima 2002 A novel combined chemotherapy using TS-1 and low-dose cisplatin against liver metastasis of gastric cancer Jpn J Cancer Chemother 29 1241 1245
21. T. Takahashi Y. Saikawa M. Kitajima 2003 Histological complete response in a case of advanced gastric cancer treated by chemotherapy with S-1 plus low-dose cisplatin and radiation Jpn J Clin Oncol 33 584 588
22. S. Nakagawa A. Nashimoto H. Yabusaki 2007 Role of staging laparoscopy with peritoneal lavage cytology in the treatment of locally advanced gastric cancer Gastric Cancer 10 29 34
23. K.Y. Song J.J. Kim C.H. Park 2007 Staging laparoscopy for advanced gastric cancer: is it also useful for the group which has an aggressive surgical strategy? World J Surg 31 1228 1233